Exendin-4 (CAS 141758-74-9) Hypoglycemic Peptide API

Exendin-4 (CAS 141758-74-9) is a high-activity hypoglycemic peptide API, renowned for its simulation of GLP-1 biological functions. With excellent molecular activity and structural stability, it effectively lowers blood glucose by promoting insulin secretion and inhibiting glucagon release, while exerting potent appetite-suppressing and fat-reducing effects.

Produced via advanced peptide synthesis technology and strict quality control, this API guarantees high purity (>98%) and consistent biological activity. It is ideal for pharmaceutical R&D institutions, biotech companies focusing on antidiabetic drugs, weight management formulations, and metabolic disorder research. Whether for preclinical trials or small-batch production, Exendin-4 delivers reliable performance, meeting the rigorous requirements of peptide drug development and providing a premium raw material solution for targeted research and formulation needs.